Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Other Accumulated Expenses (2023 - 2026)

Abpro Holdings' (ABPO) quarterly Other Accumulated Expenses came in at $722000.0 in Q1 2026, down 26.55% YoY from $983000.0 in Q1 2025, and down 32.14% on a QoQ basis from $1.1 million in Q4 2025.

Abpro Holdings (ABPO) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 4 years of Other Accumulated Expenses data on file, last reported at $722000.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 26.55% year-over-year to $722000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $722000.0 (down 26.55% YoY) and the FY2025 annual result came in at $1.1 million, up 23.01% from the prior year.
  • Other Accumulated Expenses eased to $722000.0 in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q3 2024 to a low of $590000.0 in Q4 2023.
  • A 4-year average of $1.3 million and a median of $1.0 million in 2025 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 46.61% — and 2025, when it tumbled 55.33%.
  • Tracing ABPO's Other Accumulated Expenses over 4 years: stood at $590000.0 in 2023, then soared by 46.61% to $865000.0 in 2024, then climbed by 23.01% to $1.1 million in 2025, then plunged by 32.14% to $722000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $722000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Abpro Holdings 1.14 Mn 1.14 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 722,000.00
Dec 31, 2025 1.06 Mn
Sep 30, 2025 1.01 Mn
Jun 30, 2025 1.23 Mn
Mar 31, 2025 983,000.00
Dec 31, 2024 865,000.00
Sep 30, 2024 2.27 Mn
Jun 30, 2024 2.23 Mn
Mar 31, 2024 1.71 Mn
Dec 31, 2023 590,000.00